Potential Oxidative Pathways of Catecholamines in the Formation of Lipid Peroxides and Genesis of Heart Disease
- 75 Downloads
Results of clinical and experimental animal studies have shown that unusually high levels of catecholamines in the blood cause a variety of morphological and functional changes in the heart (1, 18, 22, 25, 28). The endogenous stores of adenine triphosphate and creatine phosphate are depleted (8, 25, 26) and mitochondrial structure-function is impaired (7, 15). Intracellular increase in calcium has been considered to be a determinant factor in this as well as in variety of other models of heart cell damage (8, 21). In this regard catecholamine-induced cardiomyopathy, has been shown to be accompanied by a significant increase in the myocardial calcium content (8,15) indicating changes in the membrane permeability. Strong evidence for the alterations in the permeability of sarcolemma due to isoproterenol treatment was provided by the intracellular diffusion of horseradish peroxidase, an extracellular protein tracer, following the drug injection (19).
KeywordsDeficient Animal High Energy Phosphate Lipid Peroxide Formation Painful Stress Intracellular Diffusion
Unable to display preview. Download preview PDF.
- 1.AVIADO, D.M., WNUCK, A.L. & DE BEER, E.J. Cardiovascular effects of sympathomimetic bronchodilators: epinephrine, ephedrine, pseudoephedrine, isoproterenol, methoxyphenamine and isoprophenamine. J. Pharmacol. Exp. Therap. 122, 406–417 (1958).Google Scholar
- 2.BARBER, A.A. & BERNHEIM, F. Lipid peroxidation: its measurement, occurrence and significance in animal tissue. Adv. Gerontal. Res. 2, 355–403 (1967).Google Scholar
- 7.DHALLA, N.S., SINGAL, P.K. & DHILLON, K. Mitochondrial functions and drug-induced heart disease. In: Drug-Induced Heart Disease, Vol. 5 (Bristow, M.R., ed.) North-Holland Biomedical Press, New York, 39–61 (1980).Google Scholar
- 12.LEVI, L. Neuroendocrinology of anxiety. In: Studies of Anxiety (Lader, M.H., ed.) Headley, London, P. 40 (1970).Google Scholar
- 18.RONA, G., CHAPPEL, C.I., BALAZS, T. & Gaudry, R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. A.M.A. Archiv. Pathol. 67, 443–455 (1959).Google Scholar
- 19.RONA, G., HUTTNER, I., BOUTET, M. & Badonnel, M.-C. Coronary microcirculatory factors in cardiac muscle cell injury. Recent Advances in Studies on Cardiac Structure and Metabolism. 12, 559–571 (1978).Google Scholar
- 22.SINGAL, P.K., DHILLON, K.S., BEAMISH, R.E. & DHALLA, N.S. Protective effect of zinc against catecholamine-induced myo-cardiac changes: Electrocardiographic and ultrastructural studies. Lab. Invest. 44, 426–433 (1981).Google Scholar
- 24.SINGAL, P.K., DHILLON, K.S., BEAMISH, R.E., KAPUR, N. & DHALLA, N.S. Myocardial cell damage and cardiovascular changes due to I.V. infusion of adrenochrome in rats. Brit. J. Exp. Pathol. 63, 167–176 (1982).Google Scholar
- 25.SINGAL, P.K., KAPUR, N., DHILLON, K.S., BEAMISH, R.E. & DHALLA, N.S. Role of free radicals in catecholamine-induced cardiomyopathy. Can. J. Physiol. Pharmacol.(1982, in press).Google Scholar